Back to discover

Protein / target

Bone morphogenetic protein 4

Encoded byBMP4P12644Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Druggable Family
1
Research papers

Protein at a glance

Biological role

Chemoattractant

Strongest disease association

Myopia

Via encoding gene BMP4 · Genetic evidence · score 0.82

Research activity

Emerging research

1 papers · latest 2025

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including neurogenesis, vascular development, angiogenesis and osteogenesis.

View complete UniProt function annotation

Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including neurogenesis, vascular development, angiogenesis and osteogenesis (PubMed:31363885). Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction (By similarity). Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2 (PubMed:25868050, PubMed:8006002). Once all three components are bound together in a complex at the cell surface, BMPR2 phosphorylates and activates BMPR1A. In turn, BMPR1A propagates signal by phosphorylating SMAD1/5/8 that travel to the nucleus and act as activators and repressors of transcription of target genes (PubMed:25868050, PubMed:29212066). Positively regulates the expression of odontogenic development regulator MSX1 via inducing the IPO7-mediated import of SMAD1 to the nucleus (By similarity). Required for MSX1-mediated mesenchymal molar tooth bud development beyond the bud stage, via promoting Wnt signaling (By similarity). Acts as a positive regulator of odontoblast differentiation during mesenchymal tooth germ formation, expression is repressed during the bell stage by MSX1-mediated inhibition of CTNNB1 signaling (By similarity). Able to induce its own expression in dental mesenchymal cells and also in the neighboring dental epithelial cells via an MSX1-mediated pathway (By similarity). Can also signal through non-canonical BMP pathways such as ERK/MAP kinase, PI3K/Akt, or SRC cascades (PubMed:31363885). For example, induces SRC phosphorylation which, in turn, activates VEGFR2, leading to an angiogenic response (PubMed:31363885)

Subcellular location

Secreted, extracellular space, extracellular matrix
Domains and Gene Ontology detail (109)

Gene Ontology

  • Cendoplasmic reticulum lumen
  • Cextracellular region
  • Cextracellular space
  • FBMP receptor binding
  • Fchemoattractant activity
  • Fco-receptor binding
  • Fcytokine activity
  • Fgrowth factor activity
  • Fheparin binding
  • Paortic valve morphogenesis
  • Pblood vessel endothelial cell proliferation involved in sprouting angiogenesis
  • PBMP signaling pathway

408 aa · 47 kDa

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Cell proliferation & survivalGOCell migrationGOTranscriptional regulationUniProt · GOImmune signallingGOApoptosis & cell deathGO
View supporting evidence

Cell proliferation & survival

  • ·negative regulation of cell population proliferation
  • ·positive regulation of cell population proliferation

Cell migration

  • ·negative regulation of vascular associated smooth muscle cell migration
  • ·positive regulation of cardiac neural crest cell migration involved in outflow tract mor…

Transcriptional regulation

  • ·Growth factor of the TGF-beta superfamily that plays essential roles in many development…
  • ·gene expression
  • ·negative regulation of DNA-templated transcription
  • ·negative regulation of gene expression

Immune signalling

  • ·cytokine activity
  • ·negative regulation of immature T cell proliferation in thymus
  • ·negative regulation of T cell differentiation in thymus
  • ·positive regulation of cardiac neural crest cell migration involved in outflow tract mor…

Apoptosis & cell death

  • ·negative regulation of thymocyte apoptotic process
  • ·positive regulation of apoptotic process
  • ·positive regulation of programmed cell death

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene BMP4

Gene-level evidence surfaced through the gene BMP4 that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Myopia
0.86Well supported

Genetic evidence dominant · Open Targets 0.52

Refractive Errors
0.77Well supported

Genetic evidence dominant · Open Targets 0.47

Hypertension
0.71Moderately supported

Genetic evidence dominant · Open Targets 0.43

Colonic Neoplasms
0.70Moderately supported

Genetic evidence dominant · Open Targets 0.42

Neurodegenerative Diseases
0.31Preliminary

Pathway evidence dominant · Open Targets 0.46 · no direct causal or clinical evidence

View evidence synthesis (5)
MyopiaWell supported
0.86
agreement 0.740.98
Genetic79%Animal model15%Literature6%

Open Targets aggregate 0.52 · 3 independent evidence families

Refractive ErrorsWell supported
0.77
agreement 0.630.91
Genetic100%Literature0%

Open Targets aggregate 0.47 · 2 independent evidence families

HypertensionModerately supported
0.71
agreement 0.570.85
Genetic87%Literature13%

Open Targets aggregate 0.43 · 2 independent evidence families

Colonic NeoplasmsModerately supported
0.70
agreement 0.560.83
Genetic96%Literature4%

Open Targets aggregate 0.42 · 2 independent evidence families

Neurodegenerative DiseasesPreliminary
0.31
agreement 0.130.48
Pathway99%Literature1%

Open Targets aggregate 0.46 · 2 independent evidence families · no direct causal or clinical evidence

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Myopia0.52
Refractive Errors0.47
Neurodegenerative Diseases0.46
Hypertension0.43
Colonic Neoplasms0.42

Tractability

Small moleculesEmerging

Feasibility evidence (druggable family) — no clinical-stage drug of this modality recorded.

AntibodiesEmerging

Feasibility evidence (go cc high conf and uniprot loc med conf) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (database ubiquitination and small molecule binder) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (6)
SM · Druggable FamilyAB · GO CC high confAB · UniProt loc med confAB · UniProt SigP or TMHMMPR · Database UbiquitinationPR · Small Molecule Binder

Raw Open Targets tractability assessment buckets, by modality.

Research activity

1 papers · to 2025

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Recent

Europe PMC papers linked directly to this protein.

Related family literature

2

Papers about “Bone Morphogenetic Proteins” — a broader family this protein belongs to. Shown as context; not counted as papers specifically about this protein.

The modulatory role of bone morphogenetic protein signaling in cerebellar synaptic plasticity.

Hirono M · Journal of neurochemistry · 2025

via Bone Morphogenetic Proteins

Sclerostin and Cardiovascular Disease.

Tobias JH · Current osteoporosis reports · 2023

via Bone Morphogenetic Proteins

Europe PMC literature, reached through curated HGNC family membership. Membership is a taxonomic relationship — it does not imply this protein participates in every mechanism these papers discuss.